Sgki-105 Jun 2026

Sgk1-105, as an inhibitor of SGK1, is used in research to block or modulate the activity of SGK1. By inhibiting SGK1, Sgk1-105 can help researchers study the kinase's role in cellular processes and disease models. This can provide insights into potential therapeutic targets for various conditions.

If you can provide additional context (e.g., company name, disease area, or where you saw “SGKI-105”), I can refine this report significantly. sgki-105

| Parameter | Hypothetical Data | |-----------|------------------| | Molecular Weight | ~350–500 Da | | Solubility | Moderate (logP ~2.5) | | Oral bioavailability | >30% (if optimized) | | t1/2 (rodent) | 2–4 hours | | Target (proposed) | SGK1, PKC, or other kinase | | In vitro potency | IC50: 10–100 nM (hypothetical) | | Selectivity panel | >50% off-target inhibition unlikely | Sgk1-105, as an inhibitor of SGK1, is used

Sgk1-105 is a valuable research tool for studying SGK1's role in cellular processes and disease. By understanding its applications, handling procedures, and experimental considerations, researchers can effectively utilize Sgk1-105 in their studies. If you can provide additional context (e

Dispose of Sgk1-105 and its waste according to local regulations and guidelines for chemical disposal.

Specific formulations are approved for children aged 10 and older, focusing on managing blood sugar levels safely during development. 4. Broader Biological Implications (SGK1)